We quantified ATOH1 protein in 65 specimens from 11 LS to 54 ES patients with SCLC from the CHEMORES protocol and 37 specimens from LS patients with SCLC enrolled in the concurrent once-daily versus twice-daily chemoradiotherapy trial (STAR Methods; Table S4). This evidence concerns the gene ATOH1 and small cell lung carcinoma.